Trending News
News
News
Antibody Inhibits Broad Range of Sarbecoviruses
Scientists have discovered an antibody that may lead to more effective treatments against a wide range of sarbecoviruses, the family of viruses that includes the coronavirus SARS-CoV-2 and their variants.
News
Novel Approach Improves Cell Reprogramming Efficiency
Researchers have explored a novel strategy to enhance the reprogramming efficiency of human fibroblasts into heart muscle.
News
SARS-CoV-2 Antibodies Detected in Stool of Infants From Vaccinated Mothers
SARS-CoV-2 antibodies are transferred from vaccinated mothers to their babies through breastmilk.
News
Omicron Resistant to Most Monoclonal Antibodies, but Neutralized by Booster
Scientists studied the sensitivity of the Omicron variant to monoclonal antibodies used in clinical practice to prevent severe forms of the disease in people at risk, as well as to antibodies in the blood of individuals previously infected with SARS-CoV-2 or vaccinated.
News
Safety of COVID-19 Vaccines in People With Rheumatic and Musculoskeletal Diseases
A study shows that the majority of people with inflammatory rheumatic and musculoskeletal diseases tolerate their COVID vaccine well – with no difference in safety profile to that seen in the general population.
News
COVID-19 Vaccination Associated With Small but Temporary Change to the Menstrual Cycle
A new study published in Obstetrics & Gynecology found that COVID-19 vaccination may cause a small change to the timing of the menstrual cycle, but that this change is temporary.
News
mRNA Preparation Can Reprogram T Cells for Immunotherapy
According to a new study, an experimental immunotherapy can temporarily reprogram patients’ immune cells to attack a specific target.
News
Animal Vaccines Based on Self-Spreading Viruses Are Under Development
Self-spreading vaccines for animals intended to limit the spread of animal diseases or disease spillover to humans are being researched in Europe and the US.
News
mRNA Vaccine Booster Required for Protection Against Omicron
An additional “booster” dose of Moderna or Pfizer mRNA-based vaccine is needed to provide immunity against the Omicron variant of SARS-CoV-2, the virus that causes COVID-19, according to a new study.
News
Immunotherapy Effective at Treating Aggressive Forms of Endometrial Cancer
According to a new study, a cancer immunotherapy drug currently approved by the U.S. Food and Drug Administration to treat several forms of cancer is also effective for treating aggressive forms of uterine cancer.
Advertisement